Targeted therapy for cancer /
Saved in:
| Imprint: | Oxford ; New York : Oxford University Press, 2003. |
|---|---|
| Description: | xviii, 343 p., [4] p. of plates : ill. (some col.) ; 26 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4865036 |
Table of Contents:
- List of contributors
- List of abbreviations
- Section I.
- 1. The history of targeted therapy for cancer
- 2. Preclinical models for the study of targeted therapy
- Section II.
- 3. Monoclonal antibody targeting therapy: an overview
- 4. Antibody-directed enzyme prodrug therapy (ADEPT)
- 5. Monoclonal antibody targeted radionuclide therapy
- 6. Combined external beam radiotherapy and radioimmunotherapy
- Section III.
- 7. Genetic immunotherapy for cancer
- 8. Targeting of cancer gene therapy
- 9. Targeted genetic prodrug activation therapy
- 10. Antisense therapy as a targeted modality
- 11. Dendritic cells--targeting the antitumor immune response
- 12. Cell carriers for cancer gene therapy: bridging the gap between targeted vectors and systemic delivery?
- 13. Liposomal targeting of cytotoxic drugs
- 14. Targeting blood vessels in vivo by using phage display libraries
- Section IV.
- 15. Photodynamic therapy
- 16. Boron neutron capture therapy: a chemically targeted radiation modality
- Section V.
- 17. Cancer immunotherapy directed at growth factor receptors: the ErbB/HER network as a prototype
- 18. Targeting the metastatic process
- Index
